MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated Operating Expenses 2011-2026 | ARAY
Annual Operating Expenses Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 139 M | 142 M | 152 M | 152 M | 137 M | 137 M | 162 M | 165 M | 151 M | 164 M | 165 M | 161 M | 178 M | 200 M | 136 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 200 M | 136 M | 156 M |
Quarterly Operating Expenses Accuray Incorporated
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.6 M | 37.9 M | - | 30.6 M | 37.2 M | 36.6 M | - | 33.6 M | 39.9 M | 37.3 M | - | 36.4 M | 40.3 M | 36.8 M | 77 M | 35.1 M | 38.6 M | 37.1 M | 75.8 M | 35.1 M | 32.6 M | 29.9 M | 32.6 M | 29.9 M | 34.3 M | 37.2 M | 34.3 M | 37.2 M | 39.2 M | 42.6 M | 39.2 M | 42.6 M | 40.4 M | 40.2 M | 40.4 M | 40.2 M | 36.2 M | 37.9 M | 36.2 M | 37.9 M | 42.7 M | 41.1 M | 42.7 M | 41.1 M | 42.1 M | 43.1 M | 42.1 M | 43.1 M | 38.9 M | 38.8 M | 38.9 M | 38.8 M | 48.9 M | 44.3 M | 48.9 M | 58.6 M | 45.7 M | 49.1 M | 47.6 M | 49.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 77 M | 29.9 M | 40.8 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
39.5 M | $ 3.72 | 0.95 % | $ 153 M |  USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.12 | 0.12 % | $ 872 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 36.6 | -0.44 % | $ 5.45 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 62.34 | -0.76 % | $ 92.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.24 | 1.75 % | $ 1.65 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.37 | - | $ 265 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 34.21 | -1.67 % | $ 1.06 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.63 | 7.41 % | $ 39.2 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.48 | 2.66 % | $ 130 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 81.03 | -0.02 % | $ 47.4 B | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.59 | - | $ 122 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 32.72 | -4.99 % | $ 1.51 B | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.96 | 5.38 % | $ 1.19 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.3 | -2.41 % | $ 716 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 170.69 | 0.05 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.41 | 3.22 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 0.99 | 1.0 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
38.2 M | $ 96.2 | -0.04 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 84.91 | -2.23 % | $ 2.95 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.94 | -0.75 % | $ 374 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
LENSAR
LNSR
|
32.6 M | $ 5.87 | -3.22 % | $ 70.2 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.38 | 3.76 % | $ 56.1 M | USA |
 |
Medtronic PLC
MDT
|
15.3 B | $ 86.52 | -0.13 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.9 | -0.64 % | $ 576 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.69 | 2.43 % | $ 28.9 M | USA |